Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P21+3+9+0+0
S42+0-0+0+0

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

M
2017-02-16
AGLEAeglea Biotherapeutics, Inc.Orbimed Advisors LLC10%P - Purchase$5.16+109,3001,469,524+8%+$563,882
2017-02-17
ALDXAldeyra Therapeutics, Inc.Douglas RichardDirP - Purchase$4.50+40,00040,000New+$180,000
2017-02-17
ALDXAldeyra Therapeutics, Inc.Brady Todd CPres, CEOP - Purchase$4.50+22,22364,408+53%+$100,004
2017-02-17
ALDXAldeyra Therapeutics, Inc.Bronstein BenDirP - Purchase$4.50+4,44416,944+36%+$19,998
2017-02-17
ALDXAldeyra Therapeutics, Inc.Joyce Martin JosephDirP - Purchase$4.50+4,44417,944+33%+$19,998
2017-02-17
ALDXAldeyra Therapeutics, Inc.Tulipano Stephen JCFOP - Purchase$4.50+3,3333,333New+$14,999
2017-02-17
REPHRecro Pharma, Inc.Scp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$7.59-3,334766,1160%-$25,312
2017-02-17
REPHRecro Pharma, Inc.Scp Vitalife Partners II LP10%S - Sale$7.59-9,9832,292,8990%-$75,791
2017-02-17
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$80.27-230,000125,125,8040%-$18,462,790
2017-02-21
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.23+5003,698,7570%+$117
2017-02-17
MNKMallinckrodt PlcWatkins Ian JCHROP - Purchase$54.26+37526,921+1%+$20,348
2017-02-17
RXIIRxi Pharmaceuticals CorpCauwenbergh GeertPres, CEOP - Purchase$0.69+10,00097,533+11%+$6,931
2017-02-17
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$8.80+1,800183,780,3560%+$15,836
2017-02-16
STMLStemline Therapeutics IncHoberman KennethCOOS - Sale$6.42-1,508287,682-1%-$9,681
2017-02-16
STMLStemline Therapeutics IncBergstein IvanCEOS - Sale$6.42-3,6521,842,4760%-$23,446
2017-02-16
NKTRNektar TherapeuticsThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$13.14-1,96555,637-3%-$25,820
2017-02-16
NKTRNektar TherapeuticsRobin Howard WPres, CEOS - Sale$13.14-8,636169,682-5%-$113,477
2017-02-16
NKTRNektar TherapeuticsNicholson JohnSVP, COOS - Sale$13.14-3,237182,089-2%-$42,534
2017-02-16
NKTRNektar TherapeuticsLabrucherie Gil MSVP, CFOS - Sale$13.14-2,35969,270-3%-$30,997
2017-02-16
NKTRNektar TherapeuticsHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$13.14-2,19563,648-3%-$28,842
2017-02-16
NKTRNektar TherapeuticsGergel Ivan P.SVP, Chief Medical OfficerS - Sale$13.14-1,45745,022-3%-$19,145
2017-02-16
NKTRNektar TherapeuticsDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$13.14-1,26134,504-4%-$16,570
M
2017-02-15
CLSDClearside Biomedical, Inc.Thorp ClayDir, 10%S - Sale$7.60-41,4854,152,849-1%-$315,105
M
2017-02-09
CBMCambrex CorpKlosk Steven MPres, CEOS - Sale$52.50-23,822175,378-12%-$1,250,684
2017-02-16
FGENFibrogen IncKurkijarvi KaleviDirS - Sale$24.45-2,00040,000-5%-$48,900
D
2017-02-16
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$167.92-1,173645,4740%-$196,966
D
2017-02-16
AGIOAgios Pharmaceuticals IncSchenkein David PCEOS - Sale+OE$50.01-6,000351,354-2%-$300,060
M
2017-02-14
REPHRecro Pharma, Inc.Scp Vitalife Partners II LP10%S - Sale$7.89-12,0652,302,882-1%-$95,171
M
2017-02-14
REPHRecro Pharma, Inc.Scp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$7.89-4,030769,450-1%-$31,789
2017-02-10
ANTBAntriabio, Inc.Welch David FDirP - Purchase$0.99+5,0001,834,5150%+$4,950
2017-02-16
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$8.65+1,800183,778,5560%+$15,570+1
D
2017-02-16
PAHCPhibro Animal Health CorpWelch Daniel ASVP, HRS - Sale+OE$29.55-5,0000-100%-$147,750-2
D
2017-02-15
PAHCPhibro Animal Health CorpCarlson Gerald KDirS - Sale+OE$29.77-12,0000-100%-$357,240-2
DM
2017-02-14
PAHCPhibro Animal Health CorpMiller Larry LeeCOOS - Sale+OE$30.00-4,5880-100%-$137,640-2
DM
2017-02-14
ACADAcadia Pharmaceuticals IncMoore Terrence OEVP, CHIEF COMMERCIAL OFFICERS - Sale+OE$39.77-157,5401,671-99%-$6,265,0950
D
2017-02-14
ACADAcadia Pharmaceuticals IncBaity GlennEVP, GCS - Sale+OE$39.66-26,36567,063-28%-$1,045,5170
2017-02-15
JNJJohnson & JohnsonStoffels PaulusEVP, Chief Scientific OffS - Sale$117.28-22,000127,650-15%-$2,580,274+1
DM
2017-02-15
ALKSAlkermes Plc.Ehrich ElliotEVP, R, D, CMO, Alkermes, Inc.S - Sale+OE$56.68-11,00049,657-18%-$623,441-2
M
2017-02-14
VVUSVivus IncNorth Tide Capital, LLC10%S - Sale$1.10-305,09012,463,800-2%-$336,250+1
2017-02-15
JAZZJazz Pharmaceuticals PlcMiller Michael PatrickSVP, US CommercialS - Sale$134.55-20016,486-1%-$26,910+1
2017-02-14
SRRASierra Oncology, Inc.Topper James NDir, 10%P - Purchase$1.35+5,925,9268,112,121+271%+$8,000,000+2
2017-02-14
EBIOEleven Biotherapeutics, Inc.McCabe John JCFOS - Sale$2.10-1,3995,930-19%-$2,938+2
2017-02-15
CTLTCatalent, Inc.Morel Donald E JrDirP - Purchase$29.27+10,00018,799+114%+$292,700+1
D
2017-02-15
DERMDermira, Inc.Griffith Christopher M.SVP Head Corp. Dev., StrategyS - Sale+OE$30.79-1,30345,113-3%-$40,118+2
D
2017-02-15
DERMDermira, Inc.Ringo William RDirS - Sale+OE$32.00-5000-100%-$16,000+2
2017-02-15
CLSNCelsion CorpMartinez Alberto R JrDirP - Purchase$0.21+45,000145,081+45%+$9,675+5
2017-02-15
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$8.46+1,800183,776,7560%+$15,228+1
DM
2017-02-13
FGENFibrogen IncNeff Thomas BCEOS - Sale+OE$23.94-38,6363,480,341-1%-$924,7650
D
2017-02-14
IRWDIronwood Pharmaceuticals IncGilbert Halley EGCS - Sale+OE$16.75-37,38565,846-36%-$626,199-1
M
2017-02-14
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.24+2,0003,698,2570%+$475
2017-02-14
DERMDermira, Inc.Bauer Eugene AChief Medical OfficerS - Sale$30.00-1,50550,467-3%-$45,153+3
M
2017-02-13
PGNXProgenics Pharmaceuticals IncBroadfin Healthcare Master Fund Ltd10%S - Sale$9.66-602,6006,997,269-8%-$5,819,720+10
2017-02-14
LFVNLifevantage CorpBeindorff Michael ADirP - Purchase$6.48+43832,984+1%+$2,839-5
D
2017-02-13
ABTAbbott LaboratoriesAllen Hubert LEVPS - Sale+OE$43.00-3,40088,457-4%-$146,2000
2017-02-14
CNABUnited Cannabis CorpRuby ChadCOOS - Sale$1.48-20,000858,760-2%-$29,663
2017-02-13
VRTXVertex Pharmaceuticals Inc / MaArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$88.39-3,792127,595-3%-$335,175-2
2017-02-13
VRTXVertex Pharmaceuticals Inc / MaAltshuler DavidEVP, Global Research, CSOS - Sale$87.68-6,403106,011-6%-$561,415-2
2017-02-13
VRTXVertex Pharmaceuticals Inc / MaLeiden Jeffrey MCEO, PresS - Sale$87.68-23,904307,085-7%-$2,095,974-2
2017-02-13
VRTXVertex Pharmaceuticals Inc / MaSachdev AmitEVP, CROS - Sale$87.68-7,684100,217-7%-$673,733-2
2017-02-13
VRTXVertex Pharmaceuticals Inc / MaChodakewitz JeffreyEVP GMDA, CMOS - Sale$87.67-5,122122,511-4%-$449,046-2
2017-02-13
VRTXVertex Pharmaceuticals Inc / MaSmith Ian FEVP, CFO, COOS - Sale$87.66-3,842135,386-3%-$336,790-2
2017-02-13
REPHRecro Pharma, Inc.Scp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$7.97-2,651773,4800%-$21,130-1
2017-02-13
REPHRecro Pharma, Inc.Scp Vitalife Partners II LP10%S - Sale$7.97-7,9372,314,8870%-$63,261-1
2017-02-14
MRKMerck & Co., Inc.Karachun Rita ASVP Fince-Global ControllerS - Sale$64.73-2,95411,675-20%-$191,227-1
2017-02-14
MNKMallinckrodt PlcTrudeau MarkPres, CEOP - Purchase$50.47+1,000262,6800%+$50,466+3
2017-02-14
ALDXAldeyra Therapeutics, Inc.Perceptive Advisors LLC10%P - Purchase$4.50+893,0252,589,451+53%+$4,018,613+8
2017-02-14
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$8.41+1,800183,774,9560%+$15,138+3
2017-02-13
LFVNLifevantage CorpMauro Garry PaulDirP - Purchase$6.72+2,43547,432+5%+$16,368+7
2017-02-13
LFVNLifevantage CorpToole David JDirP - Purchase$6.68+2,00016,662+14%+$13,360+7
2017-02-13
LFVNLifevantage CorpMetzger GeorgeDirP - Purchase$6.63+1,00024,929+4%+$6,630+7
2017-02-13
LFVNLifevantage CorpRose JustinChief Sales OfficerP - Purchase$6.75+1,50016,794+10%+$10,125+7
D
2017-02-10
MDCOMedicines Co /deO'Connor William BernardCFOS - Sale+OE$50.00-57,50220,102-74%-$2,875,100+2
2017-02-13
LFVNLifevantage CorpBeindorff Michael ADirP - Purchase$6.79+2,30032,546+8%+$15,617+7
2017-02-13
LFVNLifevantage CorpJensen Darren JayCEOP - Purchase$6.75+1,500144,958+1%+$10,125+7
A
2017-02-09
CNABUnited Cannabis CorpBlackmon EarnestPres, CEO, 10%S - Sale$1.42-50,00021,773,7090%-$70,784
M
2017-02-10
VSARVersartis, Inc.Perceptive Advisors LLC10%P - Purchase$15.30+94,0164,228,563+2%+$1,438,706-1
2017-02-13
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$8.36+1,800183,773,1560%+$15,046+2
D
2017-02-09
PAHCPhibro Animal Health CorpDagger Thomas GSVP, GC, Corp SecrS - Sale+OE$30.27-5,8930-100%-$178,3810-3
DM
2017-02-09
PAHCPhibro Animal Health CorpMiller Larry LeeCOOS - Sale+OE$30.37-97,2290-100%-$2,952,5750-3
D
2017-02-09
ALDRAlder Biopharmaceuticals IncSchatzman Randall CPres, CEOS - Sale+OE$25.03-30,000115,172-21%-$750,7560-3
M
2017-02-07
ANTBAntriabio, Inc.Welch David FDirP - Purchase$0.98+13,1001,829,515+1%+$12,857
M
2017-02-09
VVUSVivus IncNorth Tide Capital, LLC10%S - Sale$1.11-176,41012,768,890-1%-$195,2810-1
2017-02-09
KERXKeryx Biopharmaceuticals IncMadison GregPres, CEOS - Sale$5.47-1,611233,711-1%-$8,8120-9
2017-02-10
MNKMallinckrodt PlcRomano Steven J.EVP, Chief Sci. OfcrP - Purchase$49.68+1,00021,023+5%+$49,680+1+11
2017-02-10
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$8.14+1,800183,771,3560%+$14,656+1+7
D
2017-02-08
NKTRNektar TherapeuticsRobin Howard WPres, CEOS - Sale+OE$13.04-87,500178,318-33%-$1,141,0000-2
DM
2017-02-08
FGENFibrogen IncNeff Thomas BCEOS - Sale+OE$23.46-37,7983,481,177-1%-$886,7410+2
D
2017-02-08
GALEGalena Biopharma, Inc.Hudson Bay Capital Management LP10%S - Sale+OE$0.84-2,363,4412,036,559-54%-$1,985,290+6+1
2017-02-09
ALXNAlexion Pharmaceuticals IncBell LeonardDirS - Sale$126.84-246394,6480%-$31,203+1+3
2017-02-09
ALXNAlexion Pharmaceuticals IncCarmichael ClareEVP, CHROS - Sale$126.84-16734,8400%-$21,182+1+3
2017-02-09
ALXNAlexion Pharmaceuticals IncMackay MartinEVP, Global Head of R, DS - Sale$126.84-21739,743-1%-$27,524+1+3
2017-02-09
ALXNAlexion Pharmaceuticals IncMoriarty John BEVP, GCS - Sale$126.84-16746,4760%-$21,182+1+3
2017-02-09
CNABUnited Cannabis CorpBlackmon EarnestPres, CEO, 10%S - Sale$1.42-28,40021,773,7090%-$40,328
2017-02-09
CNABUnited Cannabis CorpBlackmon EarnestPres, CEO, 10%P - Purchase$1.41+21,60021,773,7090%+$30,456
M
2017-02-08
VSARVersartis, Inc.Perceptive Advisors LLC10%P - Purchase$13.72+145,8234,134,547+4%+$2,001,247+4+9
2017-02-09
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$8.07+10,000183,769,5560%+$80,696+1+8
2017-02-08
CNABUnited Cannabis CorpRuby ChadCOOS - Sale$1.44-20,000878,760-2%-$28,831
2017-02-07
BPMCBlueprint Medicines CorpThird Rock Ventures Ii, L.P.10%S - Sale$35.27-1,000,0004,666,736-18%-$35,275,000-1+1
2017-02-07
BPMCBlueprint Medicines CorpBorisy AlexisDirS - Sale$0.00-040,8420%-$0-1+1
M
2017-02-07
PGNXProgenics Pharmaceuticals IncBroadfin Healthcare Master Fund Ltd10%S - Sale$9.71-351,3007,599,869-4%-$3,410,091-2-1

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top